Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948152 · ClinicalTrials.gov registry record · NA
A Study to Determine Preferences Towards Interface Products
A NA study of Sleep Disorder; Breathing-Related, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 5
- Study locations
NCT03948152: Completed NA study of Sleep Disorder; Breathing-Related, sponsored by Philips Respironics.
NCT03948152 is a NA study of Sleep Disorder; Breathing-Related that has completed, run by Philips Respironics. The registered enrollment target is 310 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03948152, a NA study of Sleep Disorder; Breathing-Related, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 5
- Study locations
Study Summary
Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled Visits or Calls that occur during the participants 90 days documented.
Primary Outcome
Proportion of participants in each arm requiring one or more mask re-fits.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Mask Advice Tool
Study Locations (5)
Florida
- Pulmonary Disease Specialists, PA, d/b/a PDS Research - Kissimmee
Maryland
- Center for Sleep and Wake Disorders - Chevy Chase
Ohio
- Pullmonary Rehabilition Associates - Youngstown
Pennsylvania
- Berks Schuylkill Respiratory Specialists, Ltd. - Reading
South Carolina
- Bogan Sleep Consultants, LLC - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2020-02-07 |
| Phase | NA |
What the finished NCT03948152 record still lists
NCT03948152 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Sleep Disorder; Breathing-Related appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03948152 lists 5 locations in 5 states (Florida, Maryland, Ohio).
Frequently Asked Questions
What is clinical trial NCT03948152 about?
NCT03948152 is a clinical study titled "A Study to Determine Preferences Towards Interface Products". Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled ...
What is the current status of trial NCT03948152?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2019-04-18. Estimated completion is 2020-02-07.
What conditions does trial NCT03948152 study?
This clinical trial studies the following conditions: Sleep Disorder; Breathing-Related.
What interventions are being tested in trial NCT03948152?
The interventions under investigation include: Standard of Care (OTHER), Mask Advice Tool (OTHER).
Who is sponsoring clinical trial NCT03948152?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03948152 being conducted?
This trial has 5 study locations across Florida, Maryland, Ohio, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder; Breathing-Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03948152's enrollment target sits among peer trials
310 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI